REACH Market Research
Danielle Drayton is the CEO and Founder of REACH Market Research. Prior to founding their current company, Danielle held various executive positions in the biopharma market assessment field at Decision Resources Group. Danielle also has experience in academia, serving as a Visiting Assistant Professor at Mount Holyoke College and as a Postdoctoral Research Fellow at Harvard Medical School. Danielle holds a PhD in Immunobiology from Yale University and a B.S. in Microbiology & Immunology from the University of Miami.
This person is not in any teams
REACH Market Research
Rare disease drug development is growing; Market research solutions for rare diseases are not. REACH is an independent pharmaceutical market research company focused on bridging this gap by providing: High Quality and Timely Rare Disease Market Insights. We help life sciences professionals quickly find, evaluate and track rare and niche disease markets through: + Primary market research-driven reports + Tailored insights to the unique challenges faced by rare and niche disease developers + Fresh market analysis delivered in weeks, not months, to enable timely decision-making + Strategic, highly visual reports that eliminate the need to distill hundreds of pages of information